Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FACT: Ferumoxytol vs Iron Sucrose for Anemia in CKD
NCT01227616Phase 4Completed
- Sponsor
- AMAG Pharmaceuticals, Inc.
- Start
- Aug 2013
- Primary completion
- Feb 2016
- Modality
- Nanoparticles, Small Molecules
- Countries
- 3
01
Overview
A Phase 4 trial of ferumoxytol in iron deficiency anemia (IDA), sponsored by AMAG Pharmaceuticals, Inc.. Started Aug 2013; status: completed.
02
Drugs
ferumoxytol
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT01227616.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01227616.